journal article Open Access Jul 15, 2021

Cerebrospinal fluid (CSF) analysis and role in clinical neurology

View at Publisher Save 10.18231/j.ijcbr.2021.016
Abstract
Cerebrospinal fluid (CSF) is a clear fluid coursing in the intracranial and spinal compartments. By estimating the levels of various CSF components utilizing relevant techniques, diagnosis, severity and prognostication of neurological conditions like infections, subarachnoid hemorrhage, demyelinating conditions, tumor like conditions, etc. can be done.Cerebrospinal fluid (CSF) provides an extremely valuable matrix for biomarker research for several purposes such as diagnosis, prognosis monitoring and identification of prominent leads in pathways of neurological disease.
Topics

No keywords indexed for this article. Browse by subject →

References
34
[7]
Fishman RA, .Cerebrospinal fluid in diseases of the nervous system.
[13]
Tuberculous Meningitis

John M. Leonard, Roger M. Des Prez

Infectious Disease Clinics of North America 10.1016/s0891-5520(20)30376-7
[14]
Seehusen DA, Reeves MM, Fomin DA, Cerebrospinal Fluid Analysis.Am Fam Phys 2003;68(6):1103-8
[17]
Kaplan SL, Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis.Infect Dis Clin N Am 1999;13:579-94 10.1016/s0891-5520(05)70095-7
[19]
Nagy K, Skagervik I, Tumani H, Petzold A, Wick M, Kühn HJ, Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage.Clin Chem Lab Med 2013;51(11):2073-86 10.1515/cclm-2012-0783
[22]
Hegen H, Ladstätter F, Bsteh G, Auer M, Berek K, Pauli FD, Cerebrospinal fluid protein in Guillain–Barré syndrome: Need for age-dependent interpretation.Eur J Neurol 2021;28:965-73 10.1111/ene.14600
[25]
Guillain-Barré syndrome

Hugh J Willison, Bart C Jacobs, Pieter A van Doorn

The Lancet 10.1016/s0140-6736(16)00339-1
[27]
Wang Y, Springer S, Zhang M, Mcmahon KW, Kindea I, Dobbyn L, Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Proc Natl Acad Sci U S A 2015;112(31):9704-9 10.1073/pnas.1511694112
[32]
Klinke G, Richter S, Monostori P, Schmidt-Mader B, García-Cazorla A, Artuch R, Targeted cerebrospinal fluid analysis for inborn errors of metabolism on an LC‐MS/MS analysis platform.J Inherit Metab Dis 2020;43(4):712-25 10.1002/jimd.12213
[33]
Seth T, Rihab G, Casey P S, Femke S, Sunita S, Stephanie F, MicroRNA biomarkers in cerebrospinal fluid and serum reflect injury severity in human acute traumatic spinal cord injury.J Neurotrauma 2019;36(15):2358-71 10.1089/neu.2018.6256
[34]
Park SA, Han SM, Kim CE, New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease.Exp Mol Med 2020;52:556-68 10.1038/s12276-020-0418-9
Metrics
0
Citations
34
References
Details
Published
Jul 15, 2021
Vol/Issue
8(2)
Pages
73-78
License
View
Cite This Article
Juhi Aggarwal, Swati Singh, Ashutosh Rawat (2021). Cerebrospinal fluid (CSF) analysis and role in clinical neurology. International Journal of Clinical Biochemistry and Research, 8(2), 73-78. https://doi.org/10.18231/j.ijcbr.2021.016